I am not sure what is bioavailability, but is'nt not that PYL is planning to release pills into market in July before this announcement. Is this R&D linked to this release of this pill?? .
If this is related, and there is no R&D aiding this pill, then would this pill release is a failure in July??? Due to low inheritance , whatever
Yissum agreement, page-2
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add HGV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $10.93M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 133096 | 5.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.4¢ | 322989 | 1 |
View Market Depth
| Last trade - 16.12pm 05/11/2024 (20 minute delay) ? |
| HGV (ASX) Chart |
Day chart unavailable